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Objective: Chondrocyte hypertrophy followed by cartilage destruction is a crucial step for osteoarthritis
(OA) development, however, the underlying mechanism remains largely unknown. The objectives of this
study are to identify the gene that may cause cartilage hypertrophy and to elucidate its role on OA
pathogenesis.
Design: Gene expression proﬁles of cartilages from OA patients and normal subjects were examined by
microarray analysis. Expression of deiodinases, enzymes for regulation of triiodothyronine (T3) bio-
synthesis, in human and rat articular cartilage (AC) were examined by real-time quantitative reverse
transcriptase-polymerase chain reaction (qRT-PCR). Rat ACs and chondrocytes were treated with T3 to
investigate its role on chondrocyte hypertrophy and inﬂammatory reaction. Cartilage-speciﬁc Type II
deiodinase (DIO2) transgenic rats were generated using bacterial artiﬁcial chromosome harboring the
entire rat Col2a1 and human DIO2 gene. An experimental OA model was created in the animal to examine
the role of DIO2 on cartilage degeneration.
Results: DIO2 is highly expressed in OA patient AC compared to normal control. In rat AC, DIO2 is spe-
ciﬁcally expressed among deiodinases and dominantly expressed the same as in brown adipose tissue. T3
induces hypertrophic markers in articular chondrocyte and cartilage explant culture, and enhances the
effect of IL-1a on induction of cartilage degrading enzymes. Importantly, cartilage-speciﬁc DIO2 trans-
genic rats are more susceptible to knee joint destabilization and develop severe AC destruction.
Conclusion: Our ﬁndings demonstrate that upregulated expression of DIO2 in OA patient cartilage might
be responsible for OA pathogenesis by enhancing the chondrocyte hypertrophy and inﬂammatory
response.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The pathology of osteoarthritis (OA)-related joint degeneration
is characterized by progressive loss of articular cartilage (AC),





nan Toubu General Hospital,
s Research Society International. PSome of these characteristics resemble hypertrophic differentiation
of chondrocyte in growth plate cartilage during endochondral
ossiﬁcation.
In endochondral ossiﬁcation, chondrocyte hypertrophy charac-
terized by type X collagen (COL10) expression and cartilage deg-
radation mainly proceeded by matrix metalloproteinases (MMPs)
sequentially occur1. Unlike growth plate chondrocyte, articular
chondrocytes do not undergo hypertrophic differentiation in
nature. However, articular chondrocytes of an OA patient fre-
quently shows hypertrophic differentiation much like the endo-
chondral ossiﬁcation2,3. Thus, signaling molecules that regulate
chondrocyte hypertrophic change in AC during OA development
would be an interesting target for disease-modifying OA therapies.ublished by Elsevier Ltd. All rights reserved.
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and OA patients’ cartilage to identify novel genes that might be
related to chondrocyte hypertrophy in OA and revealed that deio-
dinase type II (DIO2) was one of the genes highly upregulated in OA
cartilage. Deiodinase type I (DIO1) and DIO2 are responsible for the
production of active thyroid hormone, triiodothyronine (T3), from
much less active thyroxine (T4), whereas deiodinase type III (DIO3)
inactivates both T3 and T44. Though both DIO1 and DIO2 catalyze
the production of T3, DIO2 is present in a limited number of tissues
and is considered to be involved in maintaining the intracellular T3
levels whereas DIO1 is present ubiquitously and responsible for
maintaining the circulating T3 level5. Dio2 is also known to be
regulated by a rapid post-translational ubiquitin-proteasomal
mediated mechanism. The thyroid hormone potently regulates
skeletal maturation in the growth plate by promoting cellular
hypertrophy of the chondrocyte6e8. Disturbances of thyroid func-
tion cause skeletal abnormalities and either hypothyroidism or
hyperthyroidism is associated to early onset of osteoarthropathy
involving short stature9,10. Although the effect of thyroid hormone
on growth plate chondrocyte is well known, that on AC chon-
drocyte is unclear. This fact prompted us to investigate the role of
regulation of intracellular thyroid hormone availability on OA
pathogenesis.
Here we report the gene expression level of DIO2 in OA cartilage
as well as in normal rat AC. The effects of T3 on articular chon-
drocyte and cartilage culture were also investigated. Finally,
transgenic rats speciﬁcally expressing DIO2 in cartilage were gen-
erated to examine its role on OA pathogenesis.Materials and methods
Procurement of human cartilage
All human cartilage tissues were obtained at Gunma Prefectural
Cardiovascular Center, Gunma, Japan. The use of all tissues was
approved by the Gunma Prefectural Cardiovascular Center Subjects
Committee and the Daiichi Sankyo Research Ethics Committee.
Written informed consents were provided by all subjects. ACs were
obtained from patients with advanced OA within several hours
after joint replacement surgery (age 62e89 years, n ¼ 13). All
specimens exhibited macroscopic evidence of OA, including thin-
ning and loss of cartilage. Non-arthritic knee ACs were obtained
from the autopsy within 12 h after death (control) (age 60e88
years, n ¼ 11), and were diagnosed and ensured by a pathologist
to have smooth, intact surfaces without OA-like lesions. For gene
expression analysis, full depth cartilage slices were harvested and
immersed in RNA later for 24 h at 4C, and then stored at 80C
until RNA extraction. Several pieces of cartilage were obtained from
one subject and these gene expressions were analyzed independ-
ently. The mean of these data were calculated and adopted as a
microarray and quantitative reverse transcriptase-polymerase
chain reaction (qRT-PCR) data.RNA isolation and microarray analysis
Total RNA from human cartilage samples were extracted with
Isogen (Nippon Gene, Tokyo, Japan) and further puriﬁed with
RNeasy MinElute Cleanup Kit (QIAGEN, Valencia, CA). Total RNA
quality was veriﬁed using a Bioanalyzer 2100 (Agilent). Two rounds
of ampliﬁcation and labeling were performed. Ten microgram of
labeled and fragmented cRNA were then hybridized onto a Gen-
eChip Human Genome U133 Plus 2.0 Array (Affymetrix). Post-
hybridization staining and washing were conducted and arrays
were scanned with a GeneChip Scanner 3000 (Affymetrix). Probeset signals were calculated using the Affymetrix MAS5 algorithm
from ﬁles scaled to a target signal value of 100.
AC and chondrocyte cultures
All experimental procedures were performed in accordance
with the in-house guideline of the Institutional Animal Care and
Use Committee of Daiichi Sankyo Co., Ltd. Rat ACs were isolated
from femoral and tibial condyle of male 8-week-old Spraguee
Dawley rats (Japan SLC, Shizuoka, Japan). Chondrocytes were
obtained as described previously11. Brieﬂy, AC was dissected,
washed and incubated with 1% pronase for 1 h and 0.4% colla-
genase for 3 h at 37C. Released chondrocytes were passed
through a 70-lm nylon mesh (Falcon, Franklin Lakes, NJ), washed
with Dulbecco’s modiﬁed eagle medium (DMEM) with 10% fetal
bovine serum (FBS), and then recovered by centrifugation at
1,000 rpm for 5 min at room temperature. Primary chondrocytes
were seeded at 1  105 cells/cm2 on a collagen type I-coated
plate (Iwaki, Tokyo, Japan). The cartilage explant and chon-
drocyte cultures were maintained in DMEM, supplemented with
10% FBS (Life Technologies, Inc., Carlsbad, CA) for 1 day. The
medium was replaced to serum-free DMEM and used for further
experiments. Quantitative alkaline phosphatase (ALP) activity
was measured as previously reported12.
RNA isolation and reverse transcription reaction from rat samples
Rat chondrocyte cDNA was synthesized using a TaqMan Gene
Expression Cells-to-CT Kit (Applied Biosystems, Foster City, CA).
Total RNA of rat organs and AC explants were puriﬁed as
described for human cartilage samples. cDNAwas synthesized with
random hexamer primers using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems).
Quantitative polymerase chain reaction (qPCR)
Real-time PCR were run on the ABI Prism 7900 HT sequence
detection systemwith pre-designed or custom TaqMan primer sets
(Applied Biosystems). The expression levels of genes were nor-
malized to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
or b-actin used as internal control. For absolute qRT-PCR, rat Dio1, 2,
3 cDNA were cloned, puriﬁed, and used as the standard. Primer
sequence information is available upon request.
Preparation of rCol2a1-hDIO2 bacterial artiﬁcial chromosome (BAC)
transgenic construct
A rat type II collagen gene, Col2a1 BAC clone, CH230-270L14 and
a human DIO2 BAC clone, RP11-115A24 were selected [Fig. 4(A)].
DIO2 is a selenoprotein containing selenocystein (Sec), which is
essential to the enzyme activity13. A chimeric rCol2a1-hDIO2 BAC
transgenic construct harboring full length of coding exons includ-
ing a Sec insertion sequence, which is necessary for Sec incorpo-
ration, and an intervening intron of human DIO2 in place of the
rat Col2a1 gene locus was generated [Fig. 4(B)]. The human DIO2
gene was transferred to the rat Col2a1 BAC clone by a Red/ET
Counter Selection BAC Modiﬁcation Kit (Gene Bridges, Heidelberg,
Germany)14. In brief, a rpsL-neo counter selection cassette ﬂanked
by two adjacent sequences of an intervening intron of human
DIO2 gene, was inserted into the DIO2 gene. The DIO2 gene was
subcloned into plasmid pDNR-1r (Clontech). The subcloned human
DIO2 gene fragment was ﬂanked by rat Col2a1 gene untranslated
region precisely transferred to the rat Col2a1 gene.
The chimeric rCol2a1-hDIO2 construction was sequenced
[Fig. 4(C)] and puriﬁed15. The construct was linearized with PI-SceI
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Nucleobond Plasmid Puriﬁcation kit (MACHEREY-NAGEL,
Germany).Generation of human DIO2 BAC transgenic rat
Human DIO2 BAC transgenic (hD2Tg) rats were generated by
pronuclear injection of Wistar rat fertilized eggs (Charles River
Laboratory Japan, Inc.). Transgenic founders and germ line trans-
mission were assessed by Southern blotting of NcoI-digested tail
DNA probed by the [32P]-labeled 50-UTR fragment of rat type II
collagen (Col2a1) gene. Thirteen of 176 progeny contained the
transgene.
For skeletal observation, the double stained specimens of fetal
skeleton were prepared according to Inouye’s method16.Hormone determinations
Serum total T3 and T4 concentrations were determined by using
rodent triiodothyronine ELISA test kit (Endocrine Technologies Inc,
Newark, CA) and the Total thyroxine enzyme immunoassay test kit
(BioCheck Inc., Foster City, CA), respectively.Measurement of DIO2 activity of hD2Tg rat
The ACs were isolated from femoral condyle of 8 W male wild
type (WT) and hD2Tg rats (n ¼ 5 each) and placed into 24-well
plates containing 1 mL of serum-free DMEM. DIO2 activity was
measured as described previously with modiﬁcations17. The carti-
lage explants were washed twice with the medium, replaced
with 400 mL of the medium containing 2 nM T4 and [125I]-T4
(1,00,000 cpm/100 mL), and incubated for 4 h at 37C. Mediumwere
removed and half quantity of horse serum and 50% trichloroacetic
acid were added to precipitate protein. The 125I in the supernatant
was counted with a g-counter (AccuFLEX g7000, ALOKA) and
determined as DIO2 activity.Surgical induction of rat OA model
Surgical procedure was performed on 17-week old rats18e20.
Brieﬂy, under general anesthesia, the medial collateral ligament
was transected, and the medial meniscus was removed com-
pletely. The contralateral knee joint was sham-operated through
the same approach without any ligament transection or
meniscectomy.Histology and immunohistochemistry of rat AC
Three weeks after surgery, the rats were euthanized with CO2.
The entire knee joints were prepared for light microscopy using the
standard procedures (n ¼ 7 for each genotype/sex). Brieﬂy, the
samples were preserved in 10% neutral buffered formalin, ﬁxed at
4C, and subsequently decalciﬁed in 10% ethylenediaminetetra-
acetic acid (EDTA) (pH 7.4). The samples were dehydrated in an
ethanol series and embedded in parafﬁn. Coronal sections of 4 mm
were obtained using a cryostat. Slides representing the most severe
lesion formation on the medial tibial plateau was selected and
stained with Safranin O and fast green. Destruction of cartilage was
quantiﬁed according to the OARSI grading system (n ¼ 7 for each
genotype/sex)21. For immunohistochemistry, the sections were
incubated with antibody to COL10 (Cosmo Bio, Tokyo, Japan), fol-
lowed by biotinylated secondary antibody (Dako, Glostrup, Den-
mark) (n ¼ 7 for each genotype/sex).Statistical analysis
All data were expressed as means and error bars indicate 95%
conﬁdence intervals (CIs). All the statistical analyses were per-
formed using SAS System Release 8.2 (SAS Institute Inc., Cary, NC,
USA). The statistical signiﬁcance of differences between groups
were tested by Student’s t-test.
Results
DIO2 was signiﬁcantly upregulated in OA patients cartilage
Microarray analyses were performed with samples from OA
patients (n ¼ 13) and that from control (n ¼ 11). Total RNA quality
was veriﬁed not to be degraded and internal control genes were
similarly expressed [Fig. 1(A)]22. Over 2,000 transcripts were
identiﬁed to be expressed more than 2-fold higher in OA than
control cartilage (data not shown). The expression of several rep-
resentative genes recognized to be changed in OA were also
changed23e26. These results indicate that microarray analyses were
adequately performed. Among these, we focused on DIO2 because
of its role on thyroid hormone production. DIO2 was signiﬁcantly
upregulated in individual cartilage specimens in OA patients
compared to control (P < 0.001), but DIO3 was not (P ¼ 0.132)
[Fig. 1(AeC)]. DIO1 expressionwas not detected. These results were
conﬁrmed by qRT-PCR [Fig. 1(D, E)]. The average expression level of
DIO2 in OA cartilage was >15-fold higher than that in control
(P < 0.001), but DIO3 was not (P ¼ 0.05) [Fig. 1(F, G)]. DIO1
expression was not detected (data not shown).
Dio2 was highly and speciﬁcally expressed in rat AC
As little is known about the deiodinases expression in AC, we
ﬁrst compared these in rat AC (n ¼ 4). Dio2 was expressed much
higher than other deiodinases in 8-week old rats [Fig. 2(A)]. No
signiﬁcant difference was observed between 8- and 30-week old
rats (Supplemental Fig. 1). DIO2 has been reported to be highly
expressed in the central nervous system, pituitary, brown adipose
tissue (BAT) and placenta4. We next compared the Dio2 expression
among several organs demonstrating that AC expresses Dio2 the
same as BAT (n ¼ 4) [Fig. 2(B)]. These results suggested that DIO2
dominantly regulate intracellular T3 concentration in articular
chondrocytes.
Since T3 is known to play a major role on growth plate chon-
drocyte differentiation, we hypothesized that T3 might cause
articular chondrocyte hypertrophy in OA patients. Therefore, we
further investigated the relationship between T3 and articular
chondrocyte hypertrophy.
Thyroid hormone induces chondrocyte hypertrophy and the
expression of cartilage degradation enzymes in articular
chondrocyte culture
The effects of T3 and T4 on ALP activity of articular chondrocyte
were determined as a marker of the hypertrophic phenotype. T3
increased ALP activity from a concentration of 1 pM, whereas
stimulation by T4 to the same extent required much higher con-
centration (>10 nM) in rat chondrocyte cultures (n ¼ 3) [Fig. 3(A)].
These results indicate that the effect of T3 was much greater than
that of T4 and the conversion of T4eT3 might have a certain roll on
chondrocyte hypertrophy. We next assessed the effect of T3 on the
expression of genes related to chondrocyte hypertrophy in rat
articular chondrocyte cultures (n¼ 4). Treatment with T3 increased
the expressions of hypertrophic markers (Alp; P ¼ 0.002, Col10a1;
P < 0.001) [Fig. 3(B)].
Fig. 1. Comparison of gene expression of DIO2 and 3 in cartilage from control and OA. RNA extracts from cartilage samples of controls and patients with OA were analyzed using
Affymetrix GeneChip U133 Plus 2.0 (AeC) or qRT-PCR (DeG). A. Fold change (FC) of internal control genes, well known genes to be upregulated or downregulated in OA patients
cartilage, and deiodinases transcripts in OA compared with control cartilage (OA/C). The probe set ID is the Affymetrix identiﬁer for separate probes on the microarray. B, C.
Individual signals in each control and OA cartilage sample for DIO2 (B) and DIO3 (C) probe sets. D, E. qRT-PCR was performed for the DIO2 (D) and DIO3 (E) gene of controls and
patients with OA. The graph represents expression levels from individual samples. All gene expressions were normalized to the expression of GAPDH. Relative gene expression was
expressed by setting the average expression level of control samples to 1. F, G. Average expression level for both groups of DIO2 (F) and DIO3 (G). The expression level of control
samples was set to 1.
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genesis, its effects on matrix degradative enzymes were inves-
tigated (n ¼ 4). Increased expression of a disintegrin and
metalloproteinase with thrombospondin type 1 motif-5 (Adamts5)
(P ¼ 0.004), but not of Mmp3, Mmp9, Mmp13, and Adamts4, was
observed in articular chondrocytes treatedwith T3 [Fig. 3(B)]. There
is a large body of evidence that synovial inﬂammation is implicatedin many OA symptoms27. Therefore, we examined the possibility if
T3 mediates IL-1a-induced expression of various matrix degrada-
tive enzymes in chondrocytes (n ¼ 4). IL-1a signiﬁcantly increased
the expression of matrix degradative enzymes and T3 additively
increased the expression of Adamts5, Mmp3, Mmp9, and Mmp13 in
the presence of IL-1a in rat articular chondrocyte cultures
(P ¼ 0.005, <0.001, ¼0.004, <0.001) [Fig. 3(C)]. These results
Fig. 2. Comparison of gene expression in cartilage samples and other tissues in rat. Total RNA was extracted, and the respective gene expressions were examined by absolute qRT-
PCR. A. mRNA abundance of Dio1-3 in rat AC. B. Dio2 mRNA levels in AC, heart (H), liver (L), spleen (S), kidney (K), and BAT.
H. Nagase et al. / Osteoarthritis and Cartilage 21 (2013) 514e523518suggested that T3 may have a role in enhancing the effects of
inﬂammatory mediators during the induction of matrix degrading
enzymes and worsen cartilage destruction.
Thyroid hormone induces cartilage differentiation in AC tissue
culture
It is reported that chondrocyte monolayer culture leads to a de-
differentiation, whereas three-dimensional culture maintains the
articular chondrocyte phenotype11. Thus, we investigated the effect
of T3 in the rat AC tissue culture (n ¼ 4). T3 induced the expression
of genes related to chondrocyte hypertrophy (Col10a1, Alp, osteo-
calcin (Oc), and runt-related transcription factor-2 (Runx2))
[Fig. 3(D)].Fig. 3. Thyroid hormone induced alkaline phosphatase activity and OA-related gene express
for 6 days in DMEM containing T3 or T4 at the concentrations indicated. Cells were lysed and
PCR in articular chondrocytes treated with T3 (1 nM) (B) or with IL-1a (1 ng/mL) in the pre
saline was set to 1. D. Time-dependent increase of gene expressions in the AC tissue culture
point.hD2Tg rat generation and initial characterization
To establish a rat model to understand the role of DIO2 in AC
in vivo, we generated transgenic rat lines to drive the human DIO2
gene within the cartilage [Fig. 4(AeD)]. All 11 founders obtained
transmitted the DIO2 BAC transgenic construct to the F1 pup.
Mating of heterozygote male and female rats yielded WT and
hD2Tg rats at approximately the expected frequency (1:1), and no
skeletal abnormalities were observed in the fetuses (n ¼ 5)
[Fig. 5(A)]. Male and female fertility in the hD2Tg rats were normal
(data not shown). The body weight of both male and female were
almost the same although that of female hD2Tg at age 25 and 30
weeks was lower than that of femaleWT (n¼ 10) (P¼ 0.032, 0.030)
[Fig. 5(B)]. No obvious difference in femur length was observed ation in rat articular chondrocyte and cartilage tissue. A. Rat chondrocytes were cultured
ALP activity was measured. B, C. Relative gene expression level were analyzed by qRT-
sence or absence of T3 (1 nM) (C) for 24 h. Gene expression level of cells treated with
treated with T3 (100 nM). Gene expression levels at Day 0 were set to 1 at each time
Fig. 4. rCol2a1-hDIO2 BAC transgenic construction and generation of human DIO2 BAC transgenic rats. A. Structures of the rat Col2a1 and human Dio2 BAC clone. Each BAC clone
contains the full length of coding sequence, and 50- and 30-ﬂanking sequence. B. Schematic diagram of the transgene construction. The coding region of rat Col2a1 gene (middle) was
replaced by the human DIO2 sequence (top). The chimeric rCol2a1-hDIO2 construct (bottom) has a unique NcoI fragment for transgenic rats genotyping. C. Sequence analysis for BAC
transgenic construct. The junction of the chimeric rCol2a1-hDIO2 gene was ampliﬁed from BAC transgenic construct by PCR and sequenced.
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levels were comparable inWTand hD2Tg (n¼ 10) [Fig. 5(C, D)]. The
number of white blood cells (WBCs) was examined to investigate
immunological response to human DIO2 protein, and was com-
parable in both animals (n ¼ 3e5) (Supplemental Fig. 3). Thus,
hD2Tg rats were generally in a normal and systemically euthyroid
state.
To assess the expression of exogenous human DIO2 mRNA in
hD2Tg rats, various tissues were isolated from 10 weeks of age and
qRT-PCR on DIO2 was performed. ACs and xiphisternums showed
speciﬁc expressions of DIO2 (n ¼ 4) [Fig. 5(E)]. To establish further
evidence of functional expression of DIO2 protein, DIO2 activity
was measured in AC explant culture. AC from hD2Tg rats showed
approximately 7-fold higher activity than that from WT (n ¼ 5,
P < 0.001) [Fig. 5(F)]. Together, hD2Tg rats overexpressing func-
tional DIO2 in a chondrocytes-speciﬁc manner were generated as
expected.
hD2Tg rats show advanced cartilage destruction in a surgical OA
model
To determine whether the overexpression of DIO2 leads to car-
tilage degradation in vivo, knee joints of the hind limb were har-
vested fromWT and hD2Tg rats aged 20 weeks, and their cartilages
were histologically evaluated (n ¼ 7) [Fig. 6(A)]. Both WT and
hD2Tg rats did not show any defects on the femoral or tibial
articular surfaces (OARSI score ¼ 0).
In order to conﬁrm the effect of high expression of DIO2 in AC
under pathological conditions, we created an experimental OA
model that induces instability to the knee joints. The cartilage
degradation of the hD2Tg rats was notably promoted compared to
WT littermates (n ¼ 7) [Fig. 6(B)]. Quantiﬁcation by the grading
system conﬁrmed that the overexpression of DIO2 causedsigniﬁcant promotion of cartilage degradation [Fig. 6(C)]. The car-
tilage degradation of males (P < 0.001) was more severe than that
of females (P ¼ 0.002) as observed in a mice OA model28. To further
assess the phenotypic change of articular chondrocytes, we per-
formed an immunohistochemical examination for COL10. As
expected, COL10 was upregulated in the AC of hD2Tg rats as com-
pared with WT rats (n ¼ 7) [Fig. 6(D)].
Discussion
The initial objectives of this study were to identify signaling
molecules that may regulate chondrocyte hypertrophic change in
AC during OA. We found that the expression of DIO2 is signiﬁcantly
increased in the OA cartilage. Moreover, Dio2 was highly expressed
in rat AC the same as BAT4. So far, DIO2 expression in cartilage has
been examined in growth plate cartilage, but DIO2 activity was not
identiﬁed29. Accordingly, no phenotypic change in growth plate
cartilage was reported in Dio2 deﬁcient mice30,31. Our present study
revealed the high expression of Dio2 in AC of the knee joint. Dio3 is
expressed in human AC to some extent (Fig. 1) whereas Dio3
expression in rat AC is very limited [Fig. 2(A)]. The discrepancy
between human and rat Dio3 expression levels may be explained
by species difference though more precise examination will be
required.
T3 increased ALP activity as well as gene expression of Alp and
Col10 in articular chondrocyte. Similarly, the genes related to
chondrocyte hypertrophy were also induced by T3 in AC culture,
indicating that T3 enhanced hypertrophic chondrocytes differ-
entiation in AC. Compared to T3, relatively high concentration of
T4 was required despite the high expression of Dio2 [Fig. 3(A)].
This discrepancy may be explained by T4-dependent Dio2 inac-
tivation by ubiquitination32. The induction of ALP and COL10
expression by the thyroid hormone was reported in porcine and
Fig. 5. General analyses of human DIO2 BAC transgenic rats. A. The skeleton of WT (left) and hD2Tg (right) littermate fetuses (E20) stained with Alizarin red and Alcian blue. Inset
boxes in the top ﬁgures indicate tibia and ﬁbula shown in the bottom. B. Body weights of male and female WT and hD2Tg rats from 6 to 60 weeks of age. C, D. Thyroid status of WT
and hD2Tg rats. Serum T3 (C) and T4 (D) levels in 20 (top), 40 (middle), and 60 (bottom) weeks old rats. E. Human DIO2 mRNA levels of AC, xiphisternum (X), heart (H), liver (L),
spleen (S), kidney (K), artery (A), vein (V), BAT (B), and olfactory bulb (O) normalized to actin, beta in female hD2Tg rats from 10 weeks of age. F. DIO2 activity in AC of WT and hD2Tg
rats (n ¼ 5).
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results ﬁrst elucidated the possibility of pathological importance
of intracellular T3 production on articular chondrocyte hyper-
trophy observed in OA cartilage. The effect of the thyroid hormone
on cartilage degeneration has not been clearly understood. Our
results demonstrated that T3 promoted the expression of catab-
olic markers in articular chondrocyte in the inﬂammatory state.
The thyroid hormone may induce hypertrophic differentiation as
well as expression of the matrix degradative enzymes in the
inﬂammatory condition in AC. Meanwhile, anti-inﬂammatory
effects of DIO2 were reported in the primary human chon-
drocyte, suggesting that appropriate expression of DIO2 might be
important for chondrocyte homeostasis36. Moreover, increased
Dio3 rather than Dio2 expression has been associated with several
models of tissue damage37,38. Thus, intracellular T3 balanced by
Dio2 and Dio3 might be important for cell proliferation and/or
differentiation.In our preliminarily experiments, AC of the surgical instability
induced OA rats did not show the upregulation of Dio2 expression
as in OA patients. Differentially expressed genes between OA
patients and OA animal models are poorly overlapped39,40. In order
to mimic DIO2 upregulation in OA patients, human DIO2 was
overexpressed in rats. To avoid a systemic effect of DIO2 over-
expression and to determine a speciﬁc role of DIO2 in cartilage, we
generated transgenic rats overexpressing DIO2 under the control of
rat Col2a1 promoter, by which the transgene can be highly and
speciﬁcally expressed in cartilage. The resultant rats are the ﬁrst, to
our knowledge, cartilage-speciﬁc transgenic rats. This rat Col2a1
BAC gene construct might be useful to generate cartilage-speciﬁc
transgenic rats. Owing to the cartilage-speciﬁc overexpression of
DIO2, hD2Tg rats did not show any physiological abnormalities and
grew normally, though more precise analyses on linear growth and
growth plate morphology will be required. These animals show a
normal serum T3 concentration but an increased serum T4
Fig. 6. Contribution of DIO2 overexpression in cartilage to OA development in rats. A. Knee joints from male WT and hD2Tg at ages 20 weeks were harvested, processed for
histologic assessment, and 4 mm thick sections were stained with Safranin Oefast green. Representative sections are shown. Inset boxes in the left ﬁgures indicate regions shown in
the right. B. AC destruction in the medial portion 3 weeks after creating an experimental OA model with 17-week-old WT and hD2Tg rats. Tibial and femoral cartilages were stained
with Safranin O. Representative sections are shown. Inset boxes in the left ﬁgures indicate regions shown in the right. C. Cartilage destruction scores according to the OARSI grading
system. Data are expressed as means þ 95% CI for seven rats per genotype per sex at 3 weeks after the surgery. D. Immunohistochemical staining with an antibody to COL10 was
performed at 3 weeks after the surgery. Representative sections are shown.
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also demonstrated restricted expression of DIO2.
It might be possible that human DIO2 overexpressed in rat AC
induces an immunological reaction. Generally speaking, however,
transgenic animals are likely to acquire immunological tolerance
owing to its prenatal expression. To support our theory, no sig-
niﬁcant difference in the number of WBCs was observed between
WT and hD2Tg rats (Supplemental Fig. 3) suggesting that human
DIO2 might not induce an immunological reaction.
The cartilage destruction of hD2Tg rats was promoted compared
to WT rats in the surgical OA model. These results strongly support
our initial hypothesis that increased expression of DIO2 may con-
tribute to cartilage destruction in OA patients, though we did not
consider other deiodinases activities of hD2Tg rats cartilage. On the
other hand, hD2Tg rats did not show spontaneous cartilage
destruction at least up to 20 weeks old, suggesting that other
multiple stimuli, such as inﬂammation and/or mechanical stress,
may also play a role for OA development. These results support ourin vitro results of cooperative effects of inﬂammatory cytokine and
thyroid hormone on the expression of matrix degradative enzymes.
Nonetheless, it might partly but not completely explain the
mechanism of OA development in DIO2 Tg rats. For the other
potential mechanism, we have found that hypoxia-inducible factor-
2a (HIF-2a) gene expression was induced by T3 in the cartilage
tissue culture (data not shown). HIF-2a was reported to induce
chondrocyte hypertrophic differentiation as well as the gene
expressions of matrix degradative enzymes, such as MMPs and
ADAMTSs, during OA development41,42. Thus, our data supports the
theory that HIF-2a is possibly involved in the mechanism. Fur-
thermore, the expression of type II collagen is signiﬁcantly induced
in the rat OA model and human OA [Fig. 1(A)]40. Thus, expected
upregulation of hD2 induced by surgical instability might be par-
tially involved in the OA development in the hD2Tg rats.
So far, little is known about the relationship between deiodi-
nases and OA. Dio2 expression in articular chondrocyte was
reported to be increased in late OA compared to early OA, though
H. Nagase et al. / Osteoarthritis and Cartilage 21 (2013) 514e523522nothing refers to the gene24. The associations of common single
nucleotide polymorphisms in DIO2 gene with OA have been
reported43,44. The haplotype was supposed to inﬂuence the thyroid
hormone level and hip morphology in hip OA patients but not in
knee OA45e47. Although Bos et al. reported increased amount of
Dio2-positive cells in hip OA cartilage and allelic imbalance of OA
risk polymorphism48, there are several differences between knee
and hip OA; for example, primary OA of the knee is more common
than secondary OA, but primary OA of the hip is a minority. The
potential role of DIO3 in OA has also been studied and DIO3
polymorphism can modulate OA disease risk49,50. However, these
genetic analyses do not provide any answer to the functional sig-
niﬁcance of deiodinases on OA development. Our study revealed
the functional contribution of DIO2 in OA pathogenesis.
We could show the relevance of Dio2 overexpression and car-
tilage degeneration in surgical instability induced OA rats, however
our study was limited to the evaluation of only one line of hD2Tg
rats and therefore could not eliminate the possibility that Dio2 gene
was inserted into genes that are naturally protective for cartilage.
Evaluation of numerous lines from different founders to minimize
the possibility will be required. It would also be interesting to
examine whether the Dio2 deﬁcient animals are protective to OA.
In summary, we demonstrate that DIO2 is upregulated in OA
cartilage and thyroid hormone induces the hypertrophic differ-
entiation in vitro. DIO2 may regulate the OA development through
chondrocyte hypertrophy and catabolic stimuli. DIO2 over-
expression results in the hypertrophic differentiation and AC
degeneration in an experimental OA model. Our work provides a
potential therapeutic strategy for the regulation of OA cartilage
destruction through manipulation of the expression and/or activity
of DIO2 in articular chondrocytes.
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